PL209554A1 - Sposob wytwarzania cykloalkanonow cykloalkanoli i ich nienasyconych analogow - Google Patents

Sposob wytwarzania cykloalkanonow cykloalkanoli i ich nienasyconych analogow

Info

Publication number
PL209554A1
PL209554A1 PL20955478A PL20955478A PL209554A1 PL 209554 A1 PL209554 A1 PL 209554A1 PL 20955478 A PL20955478 A PL 20955478A PL 20955478 A PL20955478 A PL 20955478A PL 209554 A1 PL209554 A1 PL 209554A1
Authority
PL
Poland
Prior art keywords
cycloalcanone
cycloalkanol
making
unsaturated analogue
analogue
Prior art date
Application number
PL20955478A
Other languages
English (en)
Other versions
PL121079B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL209554A1 publication Critical patent/PL209554A1/pl
Publication of PL121079B1 publication Critical patent/PL121079B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/002—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by transformation of a functional group, e.g. oxo, carboxyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C07C37/0555—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group being esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/42—Halogenated derivatives containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/48—Preparation of compounds having groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/48—Preparation of compounds having groups
    • C07C41/50—Preparation of compounds having groups by reactions producing groups
    • C07C41/56—Preparation of compounds having groups by reactions producing groups by condensation of aldehydes, paraformaldehyde, or ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/95—Esters of quinone carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1978209554A 1977-09-13 1978-09-12 Process for preparing novel cycloalkanones PL121079B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83310277A 1977-09-13 1977-09-13

Publications (2)

Publication Number Publication Date
PL209554A1 true PL209554A1 (pl) 1979-06-04
PL121079B1 PL121079B1 (en) 1982-04-30

Family

ID=25263433

Family Applications (5)

Application Number Title Priority Date Filing Date
PL1978227876A PL122765B1 (en) 1977-09-13 1978-09-12 Method of manufacture of novel derivatives of cycloalkanes
PL1978227879A PL122834B1 (en) 1977-09-13 1978-09-12 Process for preparing novel 3-/2-hydroxy-4-/substituted/-phenyl/-cyclohexanones
PL1978227878A PL123771B1 (en) 1977-09-13 1978-09-12 Process for preparing novel cycloalkanones
PL1978227877A PL122835B1 (en) 1977-09-13 1978-09-12 Process for preparing novel cycloalkanols
PL1978209554A PL121079B1 (en) 1977-09-13 1978-09-12 Process for preparing novel cycloalkanones

Family Applications Before (4)

Application Number Title Priority Date Filing Date
PL1978227876A PL122765B1 (en) 1977-09-13 1978-09-12 Method of manufacture of novel derivatives of cycloalkanes
PL1978227879A PL122834B1 (en) 1977-09-13 1978-09-12 Process for preparing novel 3-/2-hydroxy-4-/substituted/-phenyl/-cyclohexanones
PL1978227878A PL123771B1 (en) 1977-09-13 1978-09-12 Process for preparing novel cycloalkanones
PL1978227877A PL122835B1 (en) 1977-09-13 1978-09-12 Process for preparing novel cycloalkanols

Country Status (11)

Country Link
JP (4) JPS5538367A (pl)
BE (1) BE870404A (pl)
CS (1) CS216502B2 (pl)
DD (3) DD148334A5 (pl)
HU (1) HU181937B (pl)
PL (5) PL122765B1 (pl)
PT (1) PT68543A (pl)
RO (5) RO77321A (pl)
SU (1) SU991944A3 (pl)
YU (1) YU215478A (pl)
ZA (1) ZA785180B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933475A (en) * 1980-09-19 1990-06-12 Pfizer, Inc. Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
US4921994A (en) * 1980-09-19 1990-05-01 Pfizer Inc. Pharmacologically active 2-hydroxy-4-(substituted) phenyl cycloalkanes and derivatives thereof
US4331602A (en) 1980-09-19 1982-05-25 Pfizer Inc. Pharmacologically active 4-[2-hydroxy-4-(substituted]phenyl)naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
US4835192A (en) * 1980-09-19 1989-05-30 Pfizer Inc. Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
US4486609A (en) * 1981-03-16 1984-12-04 Pfizer Inc. Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
US4831059A (en) * 1980-09-19 1989-05-16 Pfizer Inc. Producing analgesia with pharmacologically active 2-hydroxy-4-(substituted) phenyl cycloalkanes derivatives
US4285867A (en) 1980-09-19 1981-08-25 Pfizer Inc. Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
US4591225A (en) * 1985-01-14 1986-05-27 Molex Incorporated Arrangement for interconnecting a printed circuit board with a multi-conductor cable
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
CA2823724A1 (en) * 2006-04-24 2007-11-08 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
UA101004C2 (en) * 2007-12-13 2013-02-25 Теракос, Инк. Derivatives of benzylphenylcyclohexane and use thereof

Also Published As

Publication number Publication date
PL122765B1 (en) 1982-08-31
RO76721A (ro) 1982-10-11
ZA785180B (en) 1979-08-29
PL121079B1 (en) 1982-04-30
HU181937B (en) 1983-11-28
YU215478A (en) 1983-06-30
BE870404A (fr) 1979-03-12
RO77297A (ro) 1981-06-22
JPS5639031A (en) 1981-04-14
JPS5930692B2 (ja) 1984-07-28
RO77296A (ro) 1981-06-22
DD148631A5 (de) 1981-06-03
JPS5639035A (en) 1981-04-14
JPS605579B2 (ja) 1985-02-12
DD140454A5 (de) 1980-03-05
PT68543A (en) 1978-10-01
JPS5538367A (en) 1980-03-17
PL123771B1 (en) 1982-11-30
RO77321A (ro) 1981-08-17
DD148334A5 (de) 1981-05-20
RO77170A (ro) 1981-06-22
JPS5639036A (en) 1981-04-14
PL122835B1 (en) 1982-08-31
PL122834B1 (en) 1982-08-31
CS216502B2 (en) 1982-11-26
JPS5930693B2 (ja) 1984-07-28
SU991944A3 (ru) 1983-01-23
JPS5753352B2 (pl) 1982-11-12

Similar Documents

Publication Publication Date Title
DK181178A (da) Protese samt fremgangsmaade til fremstilling deraf
PL209215A1 (pl) Sposob wytwarzania analogow tiadiazolilocefalosporyn
DK274178A (da) Lyofiliseret gammaglobulinpraeparat samt fremgangsmaade til fremstilling deraf
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL207835A1 (pl) Sposob etylowania monoalkilobenzenu
DK86278A (da) Tandfyldningsmateriale samt fremgangsmaade til fremstilling deraf
PL204796A1 (pl) Sposob wytwarzania nowych pirolochinoksalinonow i pirolobenzodwuazepinonow
PL201539A1 (pl) Sposob wytwarzania maytansinolu i jego pochodnych
DK554078A (da) Tetrapeptider og fremgangsmaade til fremstilling deraf
PL207237A1 (pl) Sposob wytwarzania steroidow szeregu pregnanu
PL211702A1 (pl) Srodek grzybobojczy oraz sposob wytwarzania 1-chlorowco-1-propin-3-oli
PL209490A1 (pl) Srodek grzybobojczy oraz sposob wytwarzania podstawionych n-fenyloimidow kwasow bursztynowych
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
DK111578A (da) Steroid/spirooxazolidiner og fremgangsmaade til fremstilling deraf
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL205163A1 (pl) Srodek chwastobojczy i sposob wytwarzania nowej pochodnej glicyny
DK562478A (da) 3-di-n-propyl-acetoxy-benzodiazepin-2-oner og fremgangsmaade til fremstilling deraf
PL104948B1 (pl) Sposob otrzymywania nowych aldehydow 3-izopropenyloenantolu i 3-izopropyloenantolu
PL207682A1 (pl) Sposob wytwarzania 3-tlenkow chinazolinonu
PL201824A1 (pl) Sposob wytwarzania m-benzoiloacetofenonu
PL197764A1 (pl) Srodek szkodnikobojczy oraz sposob jego wytwarzania